I see your point a little. But NGIO on Nasdaq will be its own and Generex owns majority in it, so it rises on how well NGIO does.
Right now, Generex is not even flat. It’s rises and falls and majority of the time, it’s falling. So, unless something big happens, it needs NGIO to bring it up.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links